Literature DB >> 16331777

Primary cutaneous Nocardia otitidiscaviarum infection in a patient with rheumatoid arthritis treated with infliximab.

Sylvie Fabre1, Christelle Gibert, Catherine Lechiche, Christian Jorgensen, Jacques Sany.   

Abstract

Anti-tumor necrosis factor-a (anti-TNF-a) therapy strategies result in significant clinical benefits in patients with rheumatoid arthritis, but with an increased rate of serious infectious diseases. We describe a patient receiving infliximab who developed a primary cutaneous Nocardia otitidiscaviarum infection after a skin injury.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16331777

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


  7 in total

Review 1.  [Infectious complications of biologic therapy in patients with rheumatoid arthritis].

Authors:  D Meyer-Olson; K Hoeper; R E Schmidt
Journal:  Z Rheumatol       Date:  2010-12       Impact factor: 1.372

Review 2.  Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.

Authors:  Joshua S Davis; David Ferreira; Emma Paige; Craig Gedye; Michael Boyle
Journal:  Clin Microbiol Rev       Date:  2020-06-10       Impact factor: 26.132

3.  Disseminated nocardiosis caused by Nocardia otitidiscaviarum in an immunocompetent host: A case report and literature review.

Authors:  Yanwen Jiang; Aiben Huang; Qiuhong Fang
Journal:  Exp Ther Med       Date:  2016-09-28       Impact factor: 2.447

Review 4.  Nocardia infections among immunomodulated inflammatory bowel disease patients: A review.

Authors:  Cândida Abreu; Nuno Rocha-Pereira; António Sarmento; Fernando Magro
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

5.  Pulmonary nocardiosis in an adolescent patient with Crohn's disease treated with infliximab: a serious complication of TNF-alpha blockers.

Authors:  Rishi Verma; Ritu Walia; Stephen B Sondike; Raheel Khan
Journal:  W V Med J       Date:  2015 May-Jun

6.  Extreme evolutionary disparities seen in positive selection across seven complex diseases.

Authors:  Erik Corona; Joel T Dudley; Atul J Butte
Journal:  PLoS One       Date:  2010-08-17       Impact factor: 3.240

7.  Disseminated nocardiosis in a patient on infliximab and methylprednisolone for treatment-resistant Sweet's syndrome.

Authors:  Elizabeth R Drone; Allison L McCrory; Natalie Lane; Katherine Fiala
Journal:  Indian Dermatol Online J       Date:  2014-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.